Skip to main content
Figure 1 | Cardiovascular Diabetology

Figure 1

From: Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial

Figure 1

Cardiovascular disease event rates according to the number of additional metabolic syndrome components (risk factors) at baseline in relation to the ATPIII, IDF, harmonized, and WHO categories in patients allocated to placebo without ( n = 3837) or with ( n = 1063) prior cardiovascular disease. Apparent high event rates in the groups with no additional risk factors by the harmonized and WHO definitions are an artifact of low patient numbers.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840